Frontiers in Oncology (Aug 2022)

Primary hepatopancreatobiliary lymphoma: Pathogenesis, diagnosis, and management

  • Qianwen Wang,
  • Kangze Wu,
  • Xuzhao Zhang,
  • Yang Liu,
  • Zhouyi Sun,
  • Shumei Wei,
  • Bo Zhang

DOI
https://doi.org/10.3389/fonc.2022.951062
Journal volume & issue
Vol. 12

Abstract

Read online

Primary hepatopancreatobiliary lymphoma (PHPBL) is extremely rare, which is defined as a lympho-proliferative disease confined to the hepatobiliary system and pancreas without any involvement of lymph nodes, bone marrow, or other organs. The clinical and imaging manifestations of PHPBL are variable and non-special, which are akin to those of tumors of the hepatobiliary and pancreatic systems. The overall prognosis and management of PHPBL differ from those of other tumors in the hepatobiliary system and pancreas. Proper diagnosis and prompt treatment are essential for improving clinical outcomes. Due to its rarity, the optimal treatment has not been issued. However, combination chemotherapy is considered as a standard treatment for them. This review provides an overview of the pathogenesis, diagnosis, pathology, and management of PHPBL and offers clinicians the diagnosis and management schedule for PHPBL.

Keywords